Receptor-phosphoinositidase C coupling Multiple G-proteins?  by Lo, William W.Y. & Hughes, John
Volume 224, number 1, 1-3 FEB 05248 November 1987 




Will iam W.Y. Lo and John Hughes 
Parke-Davis Research Unit, Addenbrookes Hospital Site, Hills Road, Cambridge CB2 2QB, England 
Received 14 August 1987 
Recent evidence has suggested that receptor-mediated phosphoinositide turnover, like that of the adenylate 
cyclase cAMP pathway, isregulated by guanine nucleotides. It is likely that one or more guanine nucleotide- 
binding proteins (G-proteins) couple calcium-mobilizing receptors to the activation of phosphoinositidase 
C. Recent studies utilizing various bacterial toxins have strongly suggested the presence of multiple G-pro- 
teins in the regulation of receptor-phosphoinositidase C coupling in a variety of cell types. 
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In 1984, Berridge and Irvine [1] wrote that 
" . . . the  well established role of GTP-binding pro- 
teins in controlling cAMP production may thus be 
extended to include the regulation of other 
transduction mechanisms such as inositol 
trisphosphate formation by calcium-mobilizing 
receptors. . ." .  Since then, a large number of 
reports have accumulated which strongly suggest a
role for a GTP-binding protein (G-protein) in 
receptor-mediated phosphoinositidase C-activated 
polyphosphoinositide m tabolism [2]. Although it 
is now clear that a G-protein is essential for 
phosphoinositidase C activation, unlike that 
responsible for adenylate cyclase activation the 
identity of this G-protein is still uncertain. 
Bacterial toxins have proved to be useful tools to 
distinguish the G-proteins of the adenylate cyclase 
system. The toxins from Vibrio cholerae and 
Bordetella pertussis ADP-ribosylate G-proteins. 
While pertussis toxin ADP-ribosylates Gi and thus 
impairs the receptor-mediated inhibition of 
cyclase, cholera toxin ADP-ribosylates Gs which 
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leads to persistent stimulation of cyclase [3]. Using 
these two toxins as probes to identify the G-protein 
that regulates phosphoinositide r sponse, it seems 
that there are at least three (or even more) putative 
G-proteins involved in receptor-phosphoinositi- 
dase C coupling (table 1). 
The first, Gp is a substrate for neither pertussis 
toxin nor cholera toxin and is likely to be coupled 
to muscarinic receptors in astrocytoma cells [4] 
and cardiac myocytes [5]; angiotensin, vasopressin 
and cr~-adrenergic receptors in rat liver membranes 
[6]; TRH receptors in GH3 cells [7] and thrombin 
receptors in fibroblasts [8]. In addition, the GTP- 
binding protein encoded by ras (proto)oncogenes 
may also be involved in receptor-linked inositol 
phospholipid hydrolysis. When overexpressed, the 
p21 protein encoded by the N-ras protooncogene 
of normal, non-transformed cells greatly amplifies 
phosphoinositidase C activation to bombesin, 
vasopressin, bradykinin and platelet-derived 
growth factor (PDGF) [9]. (It is important to note 
that the analogy between ras gene products and 
other G-proteins only applies to the o~-subunits of 
the latter. A ras-specific equivalent of the ¢~/7- 
subunits of other G-proteins has not been iden- 
tified nor does p21 interact with fl/7-subunits of 
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Table 1 
Possible G-proteins involved in receptor-phosphoinositidase C coupling 
in some cell types 
G-protein Toxin Receptor Cell type 
substrate 
Gp - muscarinic [4] astrocytoma cells 
angiotensin II, 
vasopressin [6] liver membranes 
TRH [7] GH3 cells 
Go, Gi or pertussis f-Met-Leu-Phe HL-60 cells 
Go/Gi-like toxin [14-16] PMN leukocytes 
neutrophils 
compound 48/80 [17] mast cells 
thrombin [19] CCL39 cells 
bradykinin [20] F-11 cells 
G~ cholera T-cell antigen [22] Jurkat cells 
toxin CCK-8, muscarinic, 
bradykinin [25,26] Flow 9000 cells 
secretin [24] pancreatic acinar cells 
vasopressin a WRK-1 cells 
a Kirk, C.J. (personal communication) 
other G-proteins [10].) Since p21 is a substrate of 
neither cholera toxin nor pertussis toxin [11], it is 
possible that p21 may represent he putative Gp 
protein. However, it must be emphasized that op- 
posite effects on receptor-phosphoinositidase C 
coupling have been observed in some other cell 
systems when overexpressed with the ras  gene(s). 
Benjamin et al. [12] showed that in NIH-3T3 cells 
transfected with the ras  oncogene isolated from EJ 
human carcinoma (EJ-ras) there was a reduction 
of PDGF-stimulated phosphoinositidase C activi- 
ty. Similarly, a loss of PDGF receptor-activated 
phosphoinositidase C activity was observed in 
NIH-3T3 cells transfected with the v-Ha-gene [13]. 
Additional evidence must be provided to explain 
these discrepancies and to establish the role of the 
ras  gene product in receptor-mediated phospho- 
inositide metabolism. 
In contrast, activation of phosphoinositidase C 
by chemotactic peptide in HL-60 cells [14], human 
polymorphonuclear leukocytes [15] and rabbit 
neutrophil [16], by compound 48/80 in mast cells 
[17], by o~l-adrenergic agonists in adipocytes [18], 
by thrombin in hamster fibroblastic CCL39 ceils 
[19] and by bradykinin in clonal F-11 dorsal root 
ganglion hybrid cells [20] is inhibited by pertussis 
toxin pretreatment. These data suggest that the 
pertussis toxin substrate Gi, Go or a Gi/Go-like G- 
protein may be involved in the phosphoinositide 
response in some cell types. Indirect evidence from 
Snyder's laboratory showed that immunohisto- 
chemical ocalizations of Go and protein kinase C 
correspond in many areas of the brain suggesting 
a potential role for Go in the regulation of the 
phosphoinositide r sponse [21]. Reconstitution ex- 
periments using purified Go or Gi will provide 
valuable information to the above observations. 
A novel cholera toxin-sensitive G-protein (Go) 
might also be involved in mediating receptor- 
phosphoinositidase C coupling. Using the T-cell 
line Jurkat, Imboden and his colleagues reported 
that cholera toxin inhibits T-cell antigen receptor- 
mediated increases in both inositol trisphosphate 
level and cytoplasmic alcium concentration [22]. 
In the mouse macrophage cell line RAW264, 
cholera toxin has been shown to inhibit chemotaxis 
via a cAMP-independent mechanism, possibly 
through impairment of the PI response [23]. 
Moreover, secretin receptor-stimulated inositol 
trisphosphate formation in rat pancreatic acinar 
tissues was also inhibited by cholera toxin treat- 
ment [24]. In our laboratory, we found that 
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pretreatment of Flow 9000 cells (a human em- 
bryonic pituitary cell line) with cholera toxin (but 
not pertussis toxin) produces a dose-dependent i -
hibition of cholecystokinin, acetylcholine and 
bradykinin stimulation of inositol phosphate for- 
mation [25,26]. Cholera toxin treatment did not 
affect GTP analogue-induced inositol phosphate 
accumulation i permeabilized Flow 9000 cells but 
inhibited the GTP[S] potentiation of hormonal 
responses, indicating that the impairment is not at 
the GTP- or phosphoinositidase C-binding sites on 
Gc but influences the site responsible for receptor- 
Gc coupling. In WRK-1 mammary tumour cells, 
vasopressin-activated PIP2 hydrolysis is mediated 
via a G-protein [27]. Pretreatment of WRK-1 cells 
with cholera toxin, but not with pertussis toxin, 
produced a dose-dependent i hibition on vasopres- 
sin-induced inositol phosphate accumulation 
(Kirk, C.J . ,  University of Birmingham, personal 
communication). These results thus provide fur- 
ther evidence for the involvement of a novel 
cholera toxin-sensitive G-protein in inositol 
phospholipid signalling. In all of the above obser- 
vations, the cholera toxin effects cannot be 
mimicked by cAMP-generating agents indicating 
that these effects are not a consequence of ADP- 
ribosylation of Gs. 
Taken together, these findings indicate that at 
least three different G-proteins are responsible for 
regulating receptor-phosphoinositidase C coupl- 
ing. Structural evidence similar to that achieved 
for the G-proteins coupling to adenylate cyclase 
[11] will be required to confirm these observations. 
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